Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 16;12(11):1910.
doi: 10.3390/jpm12111910.

Outcomes of Returning Medically Actionable Genomic Results in Pediatric Research

Affiliations

Outcomes of Returning Medically Actionable Genomic Results in Pediatric Research

Amy A Blumling et al. J Pers Med. .

Abstract

Purpose: The electronic Medical Records and Genomics (eMERGE) Phase III study was undertaken to assess clinical utility of returning medically actionable genomic screening results. We assessed pediatric clinical outcomes following return of pathogenic/likely pathogenic (P/LP) variants in autosomal dominant conditions with available effective interventions.

Methods: The two eMERGE III pediatric sites collected outcome data and assessed changes in medical management at 6 and 12 months.

Results: We returned P/LP results to 29 participants with outcome data. For 23 of the 29 participants, the P/LP results were previously unknown. Five of the 23 participants were already followed for conditions related to the P/LP variant. Of those receiving novel results and not being followed for the condition related to the P/LP result (n = 18), 14 (77.8%) had a change in healthcare after return of results (RoR). Following RoR, cascade testing of family members occurred for 10 of 23 (43.5%).

Conclusions: The most common outcomes post-RoR included imaging/laboratory testing and health behavior recommendations. A change in healthcare was documented in 77.8% of those receiving results by 6 months. Our findings demonstrate how return of genomic screening results impacts healthcare in pediatric populations.

Keywords: genomic screening; healthcare outcomes; pediatric genomics; return of genomic results.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Participants with P/LP Results and Outcome Data by Site and Cohort.

References

    1. Yeung A., Tan N.B., Tan T.Y., Stark Z., Brown N., Hunter M.F., Delatycki M., Stutterd C., Savarirayan R., Mcgillivray G. A cost-effectiveness analysis of genomic sequencing in a prospective versus historical cohort of complex pediatric patients. Genet. Med. 2020;22:1986–1993. doi: 10.1038/s41436-020-0929-8. - DOI - PubMed
    1. Smith H.S., Swint J.M., Lalani S.R., Yamal J.-M., de Oliveira Otto M.C., Castellanos S., Taylor A., Lee B.H., Russell H.V. Clinical application of genome and exome sequencing as a diagnostic tool for pediatric patients: A scoping review of the literature. Genet. Med. 2019;21:3–16. doi: 10.1038/s41436-018-0024-6. - DOI - PubMed
    1. Cakici J.A., Dimmock D.P., Caylor S.A., Gaughran M., Clarke C., Triplett C., Clark M.M., Kingsmore S.F., Bloss C.S. A prospective study of parental perceptions of rapid whole-genome and-exome sequencing among seriously ill infants. Am. J. Hum. Genet. 2020;107:953–962. doi: 10.1016/j.ajhg.2020.10.004. - DOI - PMC - PubMed
    1. Williams J.L., Chung W.K., Fedotov A., Kiryluk K., Weng C., Connolly J.J., Harr M., Hakonarson H., Leppig K.A., Larson E.B. The Road from Nanomedicine to Precision Medicine. Jenny Stanford Publishing; Stanford, CA, USA: 2020. Harmonizing outcomes for genomic medicine: Comparison of eMERGE outcomes to ClinGen outcome/intervention pairs; pp. 871–899. - PubMed
    1. Holm I.A., Agrawal P.B., Ceyhan-Birsoy O., Christensen K.D., Fayer S., Frankel L.A., Genetti C.A., Krier J.B., LaMay R.C., Levy H.L. The BabySeq project: Implementing genomic sequencing in newborns. BMC Pediatr. 2018;18:225. doi: 10.1186/s12887-018-1200-1. - DOI - PMC - PubMed